Here we present GPNMB and SPP1 as possible new targets and could show that these genes are highly expressed in GAMs in different glioma mouse models, in human GBM, and that high expression of these genes is correlated with shorter glioma-patient survival. The gene discussed is GPNMB; the disease is glioblastoma.